Manos Perros

Manos Perros is an accomplished pharmaceutical and biotechnology executive with extensive leadership experience. Currently serving as Chairman of the Advisory Board at AUROBAC THERAPEUTICS, Manos Perros has also established a freelance career since July 2022. Previous roles include President and Chief Executive Officer at Hillstar Bio and Executive Chairman at OncXerna Therapeutics. Prior to these positions, Manos Perros was President and CEO at Entasis Therapeutics and held significant roles at AstraZeneca as Head of Infection and Site Head of Boston R&D. Manos Perros's career at Pfizer spanned over 13 years, culminating in the position of Vice President and Chief Scientific Officer for Antivirals. Educational credentials include a PhD in Biochemistry from the Pasteur Institute and postdoctoral training in Protein Biophysics at Yale University.